Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 12, 2020

SELL
$26.0 - $34.5 $405,028 - $537,441
-15,578 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$14.11 - $29.42 $219,805 - $458,304
15,578 New
15,578 $429,000

Others Institutions Holding INSM

About INSMED Inc


  • Ticker INSM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 135,476,992
  • Market Cap $9.11B
  • Description
  • Insmed Incorporated, a biopharmaceutical company, develops and commercializes therapies for patients with serious and rare diseases. The company offers ARIKAYCE for the treatment of Mycobacterium avium complex lung disease as part of a combination antibacterial drug regimen for adult patients. It is also developing Brensocatib, an oral reversibl...
More about INSM
Track This Portfolio

Track Partners Group Holding Ag Portfolio

Follow Partners Group Holding Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Partners Group Holding Ag, based on Form 13F filings with the SEC.

News

Stay updated on Partners Group Holding Ag with notifications on news.